OPKO Health, Inc.
$1.55B- Market cap
- $1.22B
- Debt
- +$687.93M
- Cash
- −$364.41M
Capital structure 64% equity / 36% debt · EV / Revenue 2.55x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: OPK stock price at premium vs VIRT $1.64 current versus $1.25 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at VIRT's multiple
Implied fair value · at OPK's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: OPK FY 2025 (ended Dec 31, 2025) · VIRT FY 2025 (ended Dec 31, 2025).
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 64% equity / 36% debt · EV / Revenue 2.55x
Capital structure 73% equity / 27% debt · EV / Revenue 1.81x · EV / EBITDA 4.64x
VIRT carries the larger enterprise value at $6.57B against $1.55B; VIRT trades on the lower EV / Revenue multiple (1.81x vs 2.55x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
OPKO Health, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Virtu Financial, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.54x
1.29x
Net debt / EBITDA
Leverage against operating earnings
-3.03x
0.69x
Cash and equivalents
Liquid reserves on the balance sheet
$364.41M
$1.06B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AMARIN CORP PLC\UK
OPK vs AMRN
Sarepta Therapeutics, Inc.
OPK vs SRPT
Amphastar Pharmaceuticals, Inc.
OPK vs AMPH
SUPERNUS PHARMACEUTICALS, INC.
OPK vs SUPN
Harmony Biosciences Holdings, Inc.
OPK vs HRMY
Interactive Brokers Group, Inc.
OPK vs IBKR
Tradeweb Markets Inc.
OPK vs TW
MARKETAXESS HOLDINGS INC
OPK vs MKTX
Cboe Global Markets, Inc.
OPK vs CBOE
NASDAQ, INC.
OPK vs NDAQ
$687.93M
$2.04B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.